Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
42m
Pembrolizumab aids survival with high-risk endometrial cancer
Pembrolizumab plus chemotherapy improves disease-free survival (DFS) in patients with high-risk endometrial cancer after ...
Oncology Nurse Advisor
34m
CLL2-BAAG Final Analysis Confirms Deep Remissions in R/R CLL With MRD-Guided Triple Therapy
Researchers sought to determine whether acalabrutinib plus venetoclax and obinutuzumab based on MRD assessment would yield deep remission in patients with R/R CLL.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Liberty win first WNBA title
The Vessel to reopen
Helicopter hits radio tower
SCOTUS rejects Cohen suit
Oscar makes landfall
WWII code talker dies
Austin visits Kyiv
Opens up on Russian camp
Gold hits fresh high
Faces new lawsuits
American activist Wair dies
Free OTC birth control plan
New Mexico flash flooding
Hezbollah assets targeted
Ceasefire talks in Beirut
Blinken's Middle East trip
Albany State shooting
NYC subway death trial
Advance to World Series
Anti-missile system in Israel
To roll out AI agents in Nov
Turkish spiritual leader dies
To name replacement in '26
Oakland fire burns homes
Launches OneWeb mission
Urges support for Ukraine
Rock & Roll HOF '24 class
CVS workers strike
Ferry dock collapses in GA
US probing documents leak
Feedback